Haemonetics (HAE) Tops Q4 EPS by 6c, Offers FY Guidance
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $77.25 -3.24%
EPS Growth %: 0.0%
Financial Fact:
Other income/(expense), net: -1.96M
Today's EPS Names:
PLCE, COE, JVA, More
EPS Growth %: 0.0%
Financial Fact:
Other income/(expense), net: -1.96M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q4 EPS of $0.65, $0.06 better than the analyst estimate of $0.59. Revenue for the quarter came in at $265 million versus the consensus estimate of $257.82 million.
GUIDANCE:
Haemonetics sees FY2023 EPS of $2.50-$2.90, versus the consensus of $2.53.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- Oracle (ORCL) Tops Q4 EPS by 16c, Offers Guidance
- United Natural Foods (UNFI) Reports In-Line Q3 EPS ; Offers Outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
